Merck spun off Organon effective June 3, 2021 in a transaction meant to be tax-free to Merck shareholders. Organon began normal trading on June 3, 2021. Merck shareholders received 0.1 shares of OGN for each share of MRK owned.
This action is a simple spinoff transaction in the accounting software. It is structured to be a non-taxable event for Merck shareholders. The cost basis allocation information is calculated from the average of the opening and closing prices of OGN and MRK on the effective date of the spinoff. Neither company has posted guidance on their websites on cost allocation at the time these instructions were written.
The cost basis allocation is dependent on the prices used for both Merck and Organon in the cost basis allocation calculations. In our experience brokers tend to use the prices found in the guidance companies post on their websites including IRS form 8937. If your broker does not use that guidance, the cost basis of the companies involved as recorded in your accounting records and in your broker’s records will not match. This is not cause for concern. This is just due to the inexact nature of the tax code in this regard. Partnership tax returns have specific areas to reconcile these usually small differences. ICLUBcentral tax printer software automatically fills in these adjustments in the normal operation of the software using the data imported from your accounting records and that you enter from your 1099.
The Spinoff Entry
Go to Transactions > Spinoff or Accounting > Securities > Record spinoff of securities depending on the version of the software being used. If you are unfamiliar with spinoff transactions you can get help at this URL: http://www.iclub.com/support/kb/default.asp?page=normal_spinoff
Here is the information you need to complete the spinoff.